Recombinant Human HAX1 Protein, N-GST & C-His

Description of Recombinant Human HAX1 Protein, N-GST & C-His

Introduction Recombinant human HAX1 protein, also known as HCLS1-associated protein X-1, is a highly conserved protein that plays an important role in various cellular processes. This protein is encoded by the HAX1 gene and is found in both humans and mice. Recombinant human HAX1 protein has been extensively studied and has shown promising potential in various applications, making it a popular choice among researchers and scientists. Structure of Recombinant Human HAX1 Protein Recombinant human HAX1 protein consists of 279 amino acids and has a molecular weight of approximately 32 kDa. It is composed of three domains: an N-terminal proline-rich domain, a central coiled-coil domain, and a C-terminal SH3 domain. The proline-rich domain is responsible for protein-protein interactions, while the coiled-coil domain is involved in the formation of protein complexes. The SH3 domain is known to bind to proline-rich motifs and is involved in signal transduction pathways. Activity of Recombinant Human HAX1 Protein Recombinant human HAX1 protein has been found to have multiple activities in different cellular processes. It is primarily known for its role in regulating apoptosis, or programmed cell death. HAX1 has been shown to interact with Bcl-2, a key regulator of apoptosis, and inhibit its pro-apoptotic activity. This interaction is crucial for maintaining cell survival and has been linked to the development and progression of various diseases, including cancer. In addition to its role in apoptosis, recombinant human HAX1 protein has also been shown to play a role in cell migration and adhesion. It interacts with the cytoskeletal protein talin and regulates its activity, which is essential for cell movement and adhesion. This activity of HAX1 is particularly important in immune cells, where it helps in their migration to sites of infection or inflammation. Moreover, recombinant human HAX1 protein has been found to be involved in mitochondrial function and energy metabolism. It interacts with the mitochondrial protein OPA1 and regulates its activity, which is crucial for maintaining mitochondrial integrity and function. This activity of HAX1 has been linked to the development of mitochondrial diseases and neurodegenerative disorders. Applications of Recombinant Human HAX1 Protein Recombinant human HAX1 protein has a wide range of applications in both research and clinical settings. Its role in regulating apoptosis makes it a potential target for cancer therapy. Studies have shown that overexpression of HAX1 can promote cancer cell survival and resistance to chemotherapy, making it a promising target for cancer treatment. On the other hand, inhibition of HAX1 has been shown to sensitize cancer cells to chemotherapy, making it a potential adjuvant therapy. In addition to cancer, recombinant human HAX1 protein has also shown potential in treating mitochondrial diseases and neurodegenerative disorders. Its role in regulating mitochondrial function and energy metabolism makes it a potential therapeutic target for these diseases. Furthermore, recombinant human HAX1 protein has been used in research to study various cellular processes, including apoptosis, cell migration, and mitochondrial function. Its availability as a recombinant protein has made it a valuable tool for scientists to study the mechanisms of these processes and their role in disease development and progression. Conclusion In conclusion, recombinant human HAX1 protein is a highly versatile and important protein that plays a crucial role in various cellular processes. Its structure, activity, and potential applications make it a popular choice among researchers and scientists. With further research and development, it has the potential to be used as a therapeutic target for various diseases, making it an exciting area of study in the field of biotechnology.